DiRx
PrivateLast Round
Series A
Dec 28, 2021
Total Funding Raised
$15M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
DiRx is a digital health company that operates an online pharmacy platform providing affordable, FDA-approved generic medications directly to consumers without the need for insurance.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, D2C Brands, E-commerce, Subscription Commerce
Business Model
B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DiRx Comparables
Compare DiRx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ScriptCo Pharmacy | 89% | |
| Mark Cuban Cost Plus Drug Company | 88% | |
| Honeybee Health | 88% | |
DiRx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 28, 2021 | ||||
| Seed | Sep 21, 2020 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2026
Grew 28% QoQ, from 25 to 32 employees.
- Jun 18, 2026
Grew 19% QoQ, from 21 to 25 employees.
DiRx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DiRx's valuation, stock price, and market status.